
SOPH Stock Forecast & Price Target
SOPH Analyst Ratings
Bulls say
Sophia Genetics is a fast-growing healthcare technology company with a strong global presence and a reputation for winning bids and positive business performance. With a focus on data diversity and advanced technology, their MSK-ACCESS and MSK-IMPACT services have shown success and are expected to contribute to continued growth and profitability. Despite challenges, SOPH has a diverse and expanding customer base and plans for further product development, making them a strong choice for long-term investment.
Bears say
Sophia Genetics is experiencing significant growth in average contract value, demonstrating potential for further expansion. However, the company's expansion plans may be hindered by its concentration in only three countries and its focus on data-driven medicine, which has not yet been widely adopted. The company's high multiples and distorted trading patterns are concerning, and it remains to be seen how their promising new exome product will perform.
This aggregate rating is based on analysts' research of Sophia Genetics SA and is not a guaranteed prediction by Public.com or investment advice.
SOPH Analyst Forecast & Price Prediction
Start investing in SOPH
Order type
Buy in
Order amount
Est. shares
0 shares